CHARLES RIVER LABORATORIES (CRL)

US1598641074 - Common Stock

270.95  +1.58 (+0.59%)

After market: 270.95 0 (0%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to CRL. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 269.35. This target is -0.59% below the current price.
CRL was analyzed by 21 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about CRL.
In the previous month the buy percentage consensus was at a similar level.
CRL was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 270.95237.35273.36269.35304.50 - -12.40% 0.89% -0.59% 12.38%
Up and Down Grades
Date Firm Action Rating
2024-03-18 Argus Research Maintains Buy -> Buy
2024-02-15 Guggenheim Downgrade Buy -> Neutral
2024-02-15 UBS Maintains Buy -> Buy
2024-02-15 Evercore ISI Group Maintains Outperform -> Outperform
2024-02-15 JP Morgan Maintains Overweight -> Overweight
2024-02-15 Baird Maintains Outperform -> Outperform
2024-02-15 Citigroup Maintains Neutral -> Neutral
2023-12-20 JP Morgan Maintains Overweight -> Overweight
2023-12-11 Citigroup Maintains Neutral -> Neutral
2023-11-10 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-11-09 UBS Maintains Buy -> Buy
2023-10-24 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-09-25 TD Cowen Maintains Market Perform -> Market Perform
2023-09-22 Guggenheim Maintains Buy -> Buy
2023-09-22 Wells Fargo Maintains Overweight -> Overweight
2023-09-22 Baird Maintains Outperform -> Outperform
2023-09-13 TD Cowen Initiate Market Perform
2023-08-10 JP Morgan Maintains Overweight -> Overweight
2023-08-10 B of A Securities Maintains Buy -> Buy
2023-07-11 Citigroup Downgrade Buy -> Neutral
2023-07-10 Citigroup Downgrade Buy -> Neutral
2023-05-15 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-05-12 Wells Fargo Maintains Overweight -> Overweight
2023-05-12 Credit Suisse Maintains Outperform -> Outperform
2023-03-28 Jefferies Maintains Hold
2023-02-23 Guggenheim Upgrade Neutral -> Buy
2023-02-23 Credit Suisse Maintains Outperform
2023-02-23 Morgan Stanley Maintains Equal-Weight
2023-02-23 Citigroup Maintains Buy
2023-01-12 Jefferies Downgrade Buy -> Hold